Skip to main content
Clinical Trials/JPRN-UMIN000001380
JPRN-UMIN000001380
Completed
Phase 4

Prognostic Value of Cardiac Sympathetic Nerve Activity Evaluated by 123I-Metaiodobenzylguanidine Imaging in Patients with ST-Segment Elevation Myocardial Infarction - Prognostic Value of 123I-MIBG in STEMI

Kitakanto Cardiovascular Hospital0 sites200 target enrollmentSeptember 17, 2008

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
ST-segment elevation myocardial infarction
Sponsor
Kitakanto Cardiovascular Hospital
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 17, 2008
End Date
September 1, 2008
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kitakanto Cardiovascular Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Hepatic failure 2\) Svere renal failure 3\) Active cancer 4\) Severe heart failure requiring mechanical support (mechanical ventilation, intraaortic balloon pumping, left ventricular assist device, or cardiac resynchronization therapy) 5\) Requiring heart transplantation

Outcomes

Primary Outcomes

Not specified

Similar Trials